Telangiectasia on the breast, those thin, visible red or purple lines created by permanently widened small blood vessels near the skin’s surface, most often results from radiation therapy after breast cancer surgery, but the list of causes extends well beyond that single scenario. Pregnancy, breast implants, certain medications, autoimmune conditions, and even rare inherited vascular disorders can all produce these markings. Understanding which cause is behind them matters because the implications range from purely cosmetic to medically significant.
Radiation Therapy Is the Most Common Cause
For anyone who has undergone breast-conserving surgery or mastectomy followed by radiation, telangiectasia is one of the most recognizable long-term skin changes. Radiation damages the tiny blood vessels in the skin, and over months to years those vessels dilate and become permanently visible. The clinical term you’ll often see is “radiation-induced breast telangiectasia,” or RIBT. It shows up as fine networks of red or purple lines across the treated area, sometimes accompanied by skin thinning or texture changes.
Not everyone who receives breast radiation develops telangiectasia, and the risk depends heavily on treatment details. Research consistently points to one factor above others: whether the patient received a “boost” dose, an additional concentrated dose of radiation aimed at the surgical scar or tumor bed. A study of post-mastectomy electron beam irradiation found that receiving a surgical scar boost was the only independently significant predictor of developing skin telangiectasia in multivariate analysis.1British Journal of Radiology. Predictive factors for skin telangiectasia following post-mastectomy electron beam irradiation – Section: Results That same study noted that shorter, uninterrupted treatment courses showed a trend toward higher telangiectasia rates as well, suggesting that the skin has less time to repair between doses.
At the genetic level, there’s a reason some patients develop telangiectasia while others receiving the same dose do not. Research has linked the risk to a specific variation in the XRCC1 gene, which plays a role in DNA repair. Patients who carry this variant appear more vulnerable to vascular endothelial cell damage from radiation, whereas the separate complication of fibrosis (thickening and scarring of tissue) tracks more closely with inflammatory responses involving a different biological pathway.2PubMed Central. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes – Section: Abstract In plain terms, telangiectasia and fibrosis after radiation are not the same injury; they arise through different mechanisms even though they often coexist in the same patient.
Other patient-related factors like body size and skin sensitivity may also play a role. The Cambridge Breast Intensity-Modulated Radiotherapy Trial found that these patient and treatment factors seemed more important than relatively small differences in dose distribution at the two-year mark after completing radiotherapy.3PubMed. The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity – Section: CONCLUSIONS
Pregnancy and Hormonal Shifts
Pregnancy rewires the vascular system in ways that frequently show up on the skin. The massive increase in circulating estrogen, progesterone, and blood volume during pregnancy causes small blood vessels to dilate, and for many women, spider telangiectasias appear on the chest and breasts alongside other vascular changes like spider veins on the legs. These develop in the majority of pregnant white women, though they are identified less often in women with darker skin, likely because they are harder to see against more pigmented skin rather than truly absent.4PubMed. Blood vessel changes during pregnancy: a review
The good news is that most pregnancy-related telangiectasias fade on their own in the months after delivery as hormone levels normalize and blood volume returns to baseline. Some persist, especially after multiple pregnancies, but they are not a sign of anything harmful. Outside of pregnancy, hormonal contraceptives and hormone replacement therapy can produce similar changes in susceptible individuals, though the effect is generally milder.
Breast Implants and Surgical Trauma
Breast augmentation introduces a physical change that stretches the skin and compresses underlying tissue, which makes blood vessels closer to the surface more visible. A retrospective study of 78 consecutive breast augmentation patients found that visible veins increased in almost all patients after surgery, with about 96% showing an increase by one or two grades on a venous prominence scale.5PubMed. Increase of visible veins after breast augmentation: a retrospective analysis of 78 consecutive breast augmentation patients While prominent veins are not the same thing as telangiectasia, the underlying mechanism overlaps: skin stretching thins the tissue between the vessel and the viewer’s eye, and the pressure from the implant can alter local blood flow patterns.
Implants can also trigger a specific pattern of redness and telangiectasia on the overlying skin. Case literature describes a condition known as telangiectatic reticular erythema, in which patients develop a reddish patch with associated telangiectasias over the implant site.6Actas Dermo-Sifiliográficas. Postimplantation Breasts Erythema, Advancing in the Knowledge of Telangiectatic Reticular Erythema These are typically asymptomatic and noticed only visually, but they can be cosmetically bothersome. The mechanism likely involves low-grade chronic stretching and pressure on the microvasculature, though the precise biology is still being studied. Any surgical procedure on the breast, not just implants, can produce localized telangiectasia along scar lines due to the disruption and regrowth of small blood vessels during healing.
Medications That Affect Blood Vessels
Some drugs used to treat breast cancer itself can paradoxically cause telangiectasia on the chest and breasts. A particularly well-documented example involves trastuzumab emtansine (T-DM1), an antibody-drug conjugate used for HER2-positive metastatic breast cancer. A case report described a 55-year-old woman who developed numerous spider telangiectasias on her upper trunk and breasts after 16 cycles of T-DM1. Each lesion had the classic spider pattern: a central arteriole with radiating branching capillaries. The proposed explanation is that HER2, the protein targeted by the drug, plays a role in keeping vascular endothelial cells alive and functioning. Blocking it may weaken those cells enough to cause abnormal dilation.7PubMed Central. Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment
Beyond cancer drugs, long-term use of topical corticosteroids on the chest area can thin the skin enough to make underlying vessels visible, producing a telangiectasia-like appearance. Systemic corticosteroids at high doses over prolonged periods can have a similar effect. These medication-related causes are worth flagging to your doctor, because in some cases switching drugs or adjusting doses can prevent further progression.
Autoimmune and Connective Tissue Conditions
Telangiectasia is one of the hallmark skin findings in several autoimmune diseases, and it can appear on the chest as part of a more widespread pattern. Systemic sclerosis (scleroderma), in particular, produces mat-like telangiectasias on the face, hands, and chest. In limited cutaneous systemic sclerosis, these visible vessels are a core diagnostic feature alongside skin thickening on the fingers and Raynaud’s phenomenon (fingers turning white or blue in the cold).
In rare cases, the overlap between radiation-induced changes and autoimmune disease creates diagnostic confusion. One case report described a breast cancer survivor who developed skin tightening and telangiectasias that were initially attributed to radiation, but who ultimately turned out to have limited cutaneous systemic sclerosis. The patient also had puffy digits, dilated capillaries at the nail folds, and facial telangiectasias, findings that together met formal diagnostic criteria for the autoimmune condition.8JAAD Case Reports. Recognizing autoimmunity in a breast cancer survivor with cutaneous fibrosis – Section: Case report The takeaway is that when telangiectasia on the breast shows up alongside symptoms elsewhere on the body, an autoimmune workup can be worth pursuing even if there’s an obvious alternative explanation like prior radiation.
Dermatomyositis and lupus can also produce telangiectasia on the chest, often as part of the characteristic V-sign rash or photosensitive skin changes seen on sun-exposed areas. Liver disease is another systemic condition that causes spider telangiectasias, typically on the upper body including the chest, due to elevated estrogen levels that the damaged liver can no longer metabolize properly.
Hereditary Hemorrhagic Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT), also called Osler-Weber-Rendu syndrome, is a genetic condition that causes abnormal blood vessel formation throughout the body. People with HHT develop telangiectasias on the skin and mucous membranes, and these can appear on the chest and breasts, though they more classically show up on the lips, tongue, fingertips, and inside the nose. The condition also involves larger vascular malformations in the lungs, brain, and liver, which carry more serious health consequences than the visible skin markings.
HHT follows an autosomal dominant inheritance pattern, meaning you need only one copy of the relevant gene variant from one parent to be affected. The most commonly involved genes are ENG and ACVRL1, which encode proteins involved in blood vessel wall signaling. Recent research using advanced genomic techniques has identified a “two-hit” mechanism for the telangiectasias themselves: a person inherits one faulty gene copy, and then a second somatic mutation in the same gene occurs in a small population of cells, knocking out both working copies and triggering the local vessel malformation.9The American Journal of Human Genetics. Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mechanism of pathogenesis – Section: Results This helps explain why telangiectasias appear in scattered spots rather than uniformly across the skin: each lesion represents a location where that second hit happened.
If you notice telangiectasias on the breast alongside recurrent nosebleeds or a family history of similar findings, it’s worth asking your doctor about HHT screening. The condition is underdiagnosed, and the internal vascular malformations it causes can lead to serious bleeding or other complications if not monitored.
When Telangiectasia Mimics Something More Serious
In rare circumstances, what appears to be telangiectasia on the breast can actually be a sign of malignancy. Carcinoma telangiectoides is a rare form of cutaneous breast cancer metastasis in which tumor cells spread into the small blood vessels of the skin, producing a reddish, telangiectasia-like appearance. Research using immunolabeling has shown that in carcinoma telangiectoides, malignant cells are found strictly within dermal blood vessels, which distinguishes it from the related condition carcinoma erysipelatoides, where tumor cells occupy lymphatic vessels instead.10PubMed. Classification of cutaneous intravascular breast cancer metastases based on immunolabeling for blood and lymph vessels – Section: RESULTS
Carcinoma telangiectoides is uncommon, but it underscores why new or rapidly changing telangiectasia on the breast in someone with a history of breast cancer should be evaluated by a doctor. The clinical appearance can be subtle. Unlike ordinary telangiectasia, it may present as a violaceous or erythematous patch that looks slightly different from the typical fine branching lines, sometimes with associated skin thickening. A biopsy can settle the question quickly.
The Quality of Life Side
Regardless of cause, breast telangiectasia can be more than a cosmetic nuisance. For breast cancer survivors in particular, visible vascular changes serve as a daily reminder of treatment. Research on patients with radiation-induced breast telangiectasia has found that these patients report substantial deficits in several quality-of-life domains, including body image, sexual functioning, and emotional well-being.11PubMed Central. Effect of laser therapy on quality of life in patients with radiation-induced breast telangiectasias – Section: CONCLUSION The telangiectasias can be physically disfiguring and psychologically distressing, particularly when they are extensive or appear on visible areas of the chest.12PubMed Central. Radiation-induced Breast Telangiectasias Treated with the Pulsed Dye Laser – Section: Abstract
This distress is often underappreciated in clinical follow-up, where the focus naturally tends to be on cancer recurrence rather than skin appearance. If the markings are bothering you, it’s entirely reasonable to bring them up with your oncologist or dermatologist. Effective treatments exist, and addressing the cosmetic concern is a legitimate part of survivorship care.
Treatment Options for Breast Telangiectasia
The two main approaches for reducing the appearance of breast telangiectasia are laser or light-based therapy and sclerotherapy. Which one makes sense depends on the size and type of vessels involved.
For the fine telangiectasias that typically follow radiation or appear with aging and hormonal changes, pulsed dye lasers (PDL) are the most studied option. PDL targets the hemoglobin inside the dilated vessels, causing them to collapse and gradually fade. Clinical practice guidelines from the Multinational Association of Supportive Care in Cancer suggest pulsed dye laser specifically for improving the visual appearance of radiation-induced telangiectasia.13SpringerLink / Support Care Cancer. Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group Intense pulsed light (IPL) is another option; comparative trials have found IPL to be similarly effective to lasers for vascular lesions, and a review of the literature confirms IPL is a safe treatment for telangiectasias, though the evidence base is limited by small study sizes and short follow-up periods.14PubMed. Intense pulsed light: a review – Section: CONCLUSION15Dermatological Reviews. Intense pulsed light for the treatment of pigmented and vascular disorders and lesions: A review – Section: Results
For larger reticular veins on the chest, sclerotherapy, injecting a solution directly into the vessel to seal it shut, can be effective. A study of sclerotherapy on telangiectasias and reticular veins of the chest found improvements of 50 to 100%, though the authors emphasized that care must be taken with sclerotherapy in the breast area; one patient developed an arterial ulceration on the lateral breast.16PubMed. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest – Section: RESULTS A newer approach using foam sclerotherapy for reticular veins of the chest showed moderate to complete resolution in most patients, with high long-term satisfaction and minor side effects.17Dermatologic Surgery. Foam Sclerotherapy for Reticular Veins of the Chest: A Retrospective Review of Efficacy and Safety – Section: Abstract
Multiple sessions are typically needed for either approach, and results depend on the underlying cause. Radiation-induced telangiectasia can be stubbornly persistent, sometimes requiring four or more laser sessions to see meaningful improvement. Telangiectasias caused by pregnancy or hormonal changes tend to respond more readily, in part because the vessels are less structurally damaged.
How Doctors Sort Through the Possibilities
When you present with telangiectasia on the breast, a dermatologist or primary care doctor will generally start with a clinical history and visual assessment. The distribution, timing, and associated symptoms tell a lot. Telangiectasia confined to one breast in a patient who had radiation to that side points strongly toward radiation-induced changes. Bilateral telangiectasia showing up during or after pregnancy suggests a hormonal cause. Spider telangiectasias scattered across the upper trunk alongside nosebleeds or a family history of similar lesions raises the possibility of HHT.
Some findings prompt additional investigation. Telangiectasia accompanied by skin tightening, especially if you also have cold-sensitivity in the fingers or swelling of the hands, warrants blood work for autoimmune markers. New-onset telangiectasia in a patient with a history of breast cancer, particularly if it looks different from the usual fine branching pattern or is changing rapidly, may require a skin biopsy to rule out carcinoma telangiectoides. If liver disease is suspected based on other signs like jaundice, palmar erythema, or spider angiomas elsewhere on the upper body, liver function tests are the next step.
In many cases, though, the evaluation is reassuring. The vast majority of breast telangiectasia is benign. It’s a cosmetic issue driven by one of the common causes, whether radiation, hormones, surgery, aging, or sun exposure on the décolletage. The vessels are permanently dilated, which means they won’t go away on their own once established, but they also aren’t doing any harm. If you want them treated for appearance, there are good options. If you’re content to leave them alone, that’s medically fine too.
Sun Exposure and Aging on the Chest
One cause that doesn’t get enough attention is cumulative sun damage on the upper chest. The skin of the décolletage is thin and frequently exposed, especially in people who wear V-neck or scoop-neck clothing year-round. Over decades, ultraviolet radiation breaks down the supportive tissue around small blood vessels, leaving them dilated and visible. This process, part of what dermatologists call photoaging, also causes the mottled pigmentation and fine wrinkling that many people notice on their chest with age.
The telangiectasias from chronic sun exposure tend to be diffuse and bilateral, often blending with other signs of sun damage. They’re sometimes grouped under the label poikiloderma of Civatte, a condition characterized by reddish-brown discoloration, telangiectasia, and mild atrophy on the sides of the neck and upper chest. IPL is one of the more effective treatments for this pattern, as it can address both the pigment changes and the vascular component in the same session.15Dermatological Reviews. Intense pulsed light for the treatment of pigmented and vascular disorders and lesions: A review – Section: Results Consistent sunscreen use on the chest can slow progression, though it won’t reverse damage that’s already done.